NEW YORK (GenomeWeb News) – PerkinElmer today said it has acquired VisEn Medical for an undisclosed amount.
In a statement, PerkinElmer said that the purchase of the in vivo molecular imaging technology firm will enhance its cellular imaging business by "expanding [its] technologies and capabilities downstream into preclinical research undertaken in academic institutes and pharmaceutical companies."